Shingles is caused by an infection of the varicella-zoster virus (VZV), but in rare cases, it may trigger neuromyelitis…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
The composition of bacteria in the gut is altered in neuromyelitis optica spectrum disorder (NMOSD) patients experiencing disease relapses…
People with neuromyelitis optica spectrum disorder (NMOSD) often have other co-occurring autoimmune diseases and those who do have a…
Neuromyelitis optica spectrum disorder (NMOSD) patients whose first symptoms affect the brainstem, which is the bottommost part of the…
Immune T-cells of the CAR T-cell therapy CT103A are able to rapidly eliminate disease-driving immune cells and reduce immune cells’…
The risk of developing type 2 diabetes is more than 50% higher among people with neuromyelitis optica spectrum disorder…
None of the neuromyelitis optica spectrum disorder (NMOSD) patients in the Phase 3 CHAMPION-NMOSD clinical trial have had a…
The U.S. Food and Drug Administration (FDA) has approved Ultomiris (ravulizumab-cwvz) to treat adults with neuromyelitis optica spectrum…
People with neuromyelitis optica spectrum disorder (NMOSD) who have experienced only one relapse tend to underestimate their risk of…
Under normal circumstances, immune B-cells train T-cells, another type of immune cell, on which targets not to attack, preventing the…